The overexpression of NFκB in AML cells abrogated the effect of SAS on PD-L1-induced resistance to chemotherapy, potentially by eliminating the ability of SAS to inhibit PD-L1 expression (Fig. 7E and F). Here, NFKB1 is linked to acute myeloid leukemia.